17:40:16 EDT Sat 04 Jul 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Canvass Ventures Ltd
Symbol CVS
Shares Issued 9,110,000
Close 2019-02-12 C$ 0.10
Recent Sedar Documents

ORIGINAL: Canvass Ventures receives conditional OK for QT

2019-05-24 19:15 ET - News Release

Received by email:

File: Canvass news re Conditional Approval and Filing Statement 24May2019.docx

CANVASS VENTURES LTD. AND NANALYSIS CORP. ANNOUNCE TSXV CONDITIONAL APPROVAL AND FILING OF FILING STATEMENT 

VANCOUVER, BRITISH COLUMBIA - May 24, 2019 - Canvass Ventures Ltd. ("Canvass" or the "Company") (TSXV: CVS.P), a capital
---> pool company, and Nanalysis Corp. ("Nanalysis"), are pleased to announce that Canvass has received conditional approval
---> from the TSX Venture Exchange ("TSXV") for its previously announced Qualifying Transaction (as defined under TSXV Polic
--->y 2.4) with Nanalysis whereby Canvass will acquire all of the outstanding class "A" common shares of Nanalysis by way of
---> a three-corner amalgamation among Canvass, Nanalysis and 2176406 Alberta Ltd, a wholly-owned subsidiary of Canvass (the
---> "Transaction"). Pursuant to the Transaction, Canvass will change its name to "Nanalysis Scientific Corp.".

Canvass and Nanalysis are also pleased to announce that Canvass has filed its filing statement dated May 24, 2019 (the "
--->Filing Statement") with respect to the Transaction.  For further details with respect to the Transaction, please see the
---> Filing Statement which is available under Canvass' profile on SEDAR at www.sedar.com.

Assuming all conditions for closing are satisfied, it is expected that the Transaction and the previously announced conc
--->urrent non-brokered private placement of Canvass for gross proceeds of up to $5,000,000 at $0.60 per unit will be comple
--->ted on or around June 4, 2019.  

Shortly after closing the Transaction, the resulting issuer is expected to commence trading on the TSXV under the tradin
--->g symbol "NSCI".

Forward-Looking Information 

This press release contains forward-looking information based on current expectations. Statements about the closing of t
--->he Transaction and the parties' ability to satisfy closing conditions and receive necessary approvals are all forward-lo
--->oking information. These statements should not be read as guarantees of future performance or results. Such statements i
--->nvolve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievemen
--->ts to be materially different from those implied by such statements. Although such statements are based on management's 
--->reasonable assumptions, there can be no assurance that the Transaction will occur or that, if the Transaction does occur
--->, it will be completed on the terms described above. Canvass and Nanalysis assume no responsibility to update or revise 
--->forward-looking information to reflect new events or circumstances unless required by law.

Cautionary Statements

Completion of the transaction is subject to a number of conditions, including but not limited to, TSXV acceptance and if
---> applicable pursuant to TSXV requirements, majority of the minority shareholder approval. Where applicable, the transact
--->ion cannot close until the required shareholder approval is obtained. There can be no assurance that the transaction wil
--->l be completed as proposed or at all. 

Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepa
--->red in connection with the transaction, any information released or received with respect to the transaction may not be 
--->accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be consid
--->ered highly speculative. 

The TSXV has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the c
--->ontents of this press release.

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsi
--->bility for the adequacy or accuracy of this release.

For further information, please contact:

Martin Burian
CEO & Director
Canvass Ventures Ltd.
martin@burian.ca
(604) 562-4871
 
Sean Krakiwsky
President and CEO
Nanalysis Corp.
sean.krakiwsky@nanalysis.com
(587) 899-0513
 
 



© 2020 Canjex Publishing Ltd. All rights reserved.